![Joseph R. Tamayo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph R.
Tamayo worked as a Director of Regulatory & Quality Affairs at Cerus Corp.
and U.S.
Stem Cell, Inc. He also worked as a VP of Regulatory Affairs & Quality Assurance at Medlogics Device Corp.
Tamayo received an undergraduate degree from Loyola Marymount University.
| Unternehmen | Position | Ende |
|---|---|---|
| U.S. STEM CELL, INC. | General Counsel | 05.05.2010 |
| CERUS CORPORATION | General Counsel | - |
Medlogics Device Corp.
 Medlogics Device Corp. Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of drug eluting coating, stent and catheter solutions | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
U.S. Stem Cell, Inc.
 U.S. Stem Cell, Inc. BiotechnologyHealth Technology Operates as biotechnology and regenerative medicine company that develops autologous stem cell therapies and products | Health Technology |
Medlogics Device Corp.
Medlogics Device Corp. Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of drug eluting coating, stent and catheter solutions | Health Technology |
Loyola Marymount University
 Loyola Marymount University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
